Michael Cho
Known title: Chief Strategy OfficerCIK: 0001530071
Associated companies
Transaction History
| ZBRA | ▼ Sell | Open Market | 3,500 | $1.3M | 8/7/2026 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 779 | $174K | 5/4/2026 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 162 | $37K | 5/2/2026 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 180 | $42K | 3/4/2026 | View on chart |
| ZBRA | ▲ Buy | Grant | 2,859 | $0 | 3/3/2026 | View on chart |
| ZBRA | ▲ Buy | Grant | 1,575 | $0 | 2/3/2026 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 144 | $37K | 12/17/2025 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 342 | $86K | 5/5/2025 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 195 | $50K | 5/4/2025 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 163 | $42K | 5/2/2025 | View on chart |
| ZBRA | ▲ Buy | Grant | 2,086 | $640K | 3/4/2025 | View on chart |
| ZBRA | ▲ Buy | Grant | 391 | $0 | 2/5/2025 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 60 | $25K | 12/7/2024 | View on chart |
| ZBRA | ▲ Buy | Option Exercise | 422 | $103K | 11/12/2024 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 124 | $50K | 11/12/2024 | View on chart |
| ZBRA | ▼ Sell | Open Market | 298 | $119K | 11/12/2024 | View on chart |
| ZBRA | ▲ Buy | Option Exercise | 266 | $40K | 5/14/2024 | View on chart |
| ZBRA | ▲ Buy | Option Exercise | 280 | $57K | 5/14/2024 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 162 | $52K | 5/14/2024 | View on chart |
| ZBRA | ▼ Sell | Open Market | 384 | $123K | 5/14/2024 | View on chart |
| ZBRA | ▼ Sell | Open Market | 1,273 | $408K | 5/14/2024 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 174 | $55K | 5/6/2024 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 114 | $35K | 5/5/2024 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 195 | $60K | 5/4/2024 | View on chart |
| ZBRA | ▲ Buy | Grant | 1,877 | $580K | 5/2/2024 | View on chart |
| ZBRA | ▼ Sell | Open Market | 1,457 | $397K | 2/21/2024 | View on chart |
| ZBRA | ▲ Buy | Grant | 372 | $0 | 2/7/2024 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 48 | $13K | 12/16/2023 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 73 | $20K | 5/6/2023 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 128 | $35K | 5/5/2023 | View on chart |
| ZBRA | ▲ Buy | Grant | 2,244 | $0 | 5/4/2023 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 390 | $112K | 4/30/2023 | View on chart |
| ZBRA | ▼ Sell | Open Market | 1,600 | $468K | 2/24/2023 | View on chart |
| ZBRA | ▲ Buy | Grant | 1,014 | $0 | 2/8/2023 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 111 | $38K | 5/6/2022 | View on chart |
| ZBRA | ▲ Buy | Grant | 1,305 | $0 | 5/5/2022 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 96 | $36K | 5/2/2022 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 708 | $269K | 5/2/2022 | View on chart |
| ZBRA | ▼ Sell | Tax Withholding | 92 | $34K | 4/30/2022 | View on chart |
| ZBRA | ▲ Buy | Grant | 1,756 | $0 | 2/3/2022 | View on chart |
| ZBRA | ▼ Sell | Open Market | 802 | $472K | 12/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Barclays Raises Zebra Technologies Price Target to $416
Barclays maintained an Overweight rating on Zebra Technologies while raising its price target to $416. This action comes as the stock has experienced a significant 71% rally over the past six months, driven largely by automation trends. With the company already trading near its 52-week high, analysts are now debating whether the current valuation leaves little room for error despite the clear recovery.
Barclays Raises Zebra Technologies Price Target to $416. Barclays maintained an Overweight rating on Zebra Technologies while raising its price target to $416. This action comes as the stock has experienced a significant 71% rally over the past six months, driven largely by automation trends. With the company already trading near its 52-week high, analysts are now debating whether the current valuation leaves little room for error despite the clear recovery.